Skip to main content
. 2021 Aug 10;3(18):5240–5254. doi: 10.1039/d1na00596k

Fig. 2. (a) Scheme of Soluplus® nanomicelle for uveitis treatment. Reproduced from ref. 58 with permission from Elsevier B.V., copyright 2021. (b) Scheme of the F127/TGPS polymeric micelle for high permeability drug delivery. Reproduced from ref. 67 with permission from the American Chemical Society, copyright 2018.

Fig. 2